Skip to content

proGAV 2.0® FX416TRecalls & reported problems

Christoph Miethke GmbH & Co. KG · PROGAV 2.0 WITH SHUNTASSISTANT 35 · Class 2 · Implant

All models of proGAV 2.0 (49)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04041906136581), received between Nov 4, 2021 and Nov 4, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Mechanical Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Mechanical Problem1

Patient problems

  • Hydrocephalus1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 4, 2021Mechanical Problem; Mechanical Problem

    ACCORDING TO THE COMPLAINANT A PROGAV COULD NOT BE ADJUSTED POSTOPERATIVELY. THE PATIENT WAS ORIGINALLY IMPLANTED ON AN UNSPECIFIED DATE. THE DATE OF THE MALFUNCTION WAS UNKNOWN, BUT IT OCCURRED APPROXIMATELY 8 MONTHS LATER. THE VALVE WAS EXPLANTED AND RETURNED TO THE MANUFACTURER FOR EVALUATION. FURTHER DETAILS WERE NOT PROVIDED.

    Patient problems: Hydrocephalus

    MAUDE report 12751934 ↗

Other Shunt, central nervous system and components devices

All Shunt, central nervous system and components devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page